Sertraline-Associated Rhabdomyolysis

Carlo Cottone¹, Francesca Chiavarino^{2

3}

Affiliations

¹ Dipartimento di Salute Mentale, Ospedale Infermi, U.O Neuropsichiatria Infantile, Rimini, Italy.
² IRCCS Istituto delle Scienze Neurologiche di Bologna, U.O.C. Neuropsichiatria dell'Età Pediatrica, Bologna, Italy.
³ Dipartimento di Scienze Mediche e Chirurgiche (DIMEC), Università di Bologna, Bologna, Italy.

Carlo Cottone et al. Am J Ther. 2023 Nov-Dec.

. 2023 Nov-Dec;30(6):e594-e597.

doi: 10.1097/MJT.0000000000001540. Epub 2022 Jul 12.

Carlo Cottone¹, Francesca Chiavarino^{2

3}

¹ Dipartimento di Salute Mentale, Ospedale Infermi, U.O Neuropsichiatria Infantile, Rimini, Italy.
² IRCCS Istituto delle Scienze Neurologiche di Bologna, U.O.C. Neuropsichiatria dell'Età Pediatrica, Bologna, Italy.
³ Dipartimento di Scienze Mediche e Chirurgiche (DIMEC), Università di Bologna, Bologna, Italy.

No abstract available

Conflict of interest statement

The authors have no conflicts of interest to declare.

1. Singh HK, Saadabadi A. Sertraline. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.
1. DeVane CL, Liston HL, Markowitz JS. Clinical pharmacokinetics of sertraline: clinical pharmacokinetics. 2002;41:1247–1266.
1. Cipriani A, La Ferla T, Furukawa TA, et al. Sertraline versus Other Antidepressive Agents for Depression. Cochrane Common Mental Disorders Group. Cochrane Database of Systematic Reviews [Internet]. 2010 Apr 14 [cited 2022 Mar 15]; Available at: https://doi.wiley.com/10.1002/14651858.CD006117 . Accessed October 15, 2021.
1. Alderman J, Wolkow R, Chung M, et al. Sertraline treatment of children and adolescents with obsessive-compulsive disorder or depression: pharmacokinetics, tolerability, and efficacy. J Am Acad Child Adolesc Psychiatry. 1998;37:386–394.
1. Hawton K, Bergen H, Simkin S, et al. Toxicity of antidepressants: rates of suicide relative to prescribing and non-fatal overdose. Br J Psychiatry. 2010;196:354–358.